FTC sues big pharmacy gain professionals more than insulin costs The company introduced motion in opposition to Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the listing price of daily life-preserving insulin prescription drugs. Listen to the write-up 10 min This audio is https://daveshotchickennutrition29628.wssblogs.com/30684849/the-smart-trick-of-healthcare-news-that-nobody-is-discussing